Dr. Schaison is a CEO, CCO and Global President in consumer healthcare, consumer goods & retail sectors across Asia, South America & Europe with experience running a $2.5B+ business growing 17% a year (Allergan), acquiring/integrating a +$2B organization, and successfully leading global organizations. His communication/interpersonal skills & ability to work effectively with boards/senior executives and build/lead high-performance teams has informed all his work.
Hired by the Chairman & Board of Directors of Syneron-Candela NA (Irvine, CA), to take a publicly traded company (ELOS) private, Dr. Schaison sold the company to Private Equity firm Apax in July 2017 for $11 a share; a two-fold increase over past trading value (Nov 2016 – $6 a share).
Earlier, as Allergan President, US Aesthetic & Dermatology, Dr. Schaison reports to the CEO and led the Facial Aesthetic, Plastic and MedDerm/Skin Medical BU Presidents. He secured market leadership for every single Botox product by leading a 2-pronged model (B2B and B2C) that enabled the organic growth of the $2.5B business by 17% a year and solidified a one-stop shopping approach with the $2.1B acquisition of Kythera. Leading an internal advertising agency, he optimizes advertising cost efficiencies/effectiveness.
Before, Dr. Schaison was President, Clarins WW Travel Retail & Regional President, LATAM and MEA. Reporting to the CEO, and leading a $1B+ business, he generated 55% of Clarins’ total net sales & 70% of its EBIT, achieving 28% growth in a single digit market.
Earlier, Dr. Schaison served as CEO for Aesthetic Factors.
As VP, Global Skin Care for Johnson & Johnson, with P&L responsibility for leading brands, he consistently exceeded financial business plan objectives. As Board Member, Ortho- Neutrogena, he enabled the entrance into the aesthetic market by recommending Colbar’s acquisition.
Dr. Schaison earned an MBA from the Hautes Etudes Commerciales, and a Doctorate in Pharmacy from the University Of Paris V.